v3.26.1
Unaudited Interim Consolidated Statement Equity - USD ($)
$ in Millions
Total
Common Stock
Treasury Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss), Net
Balance as of the beginning of the period (in shares) at Dec. 31, 2024     61,499,640      
Balance as of the beginning of the period (in shares) at Dec. 31, 2024   109,327,556        
Balance as of the beginning of the period at Dec. 31, 2024   $ 0 $ (5,486) $ 409 $ 11,054 $ (848)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock option exercises, shares   0        
Stock option exercises   $ 0        
Stock awards (in shares)   174,320        
Stock awards   $ 0        
Issuance of treasury stock under stock plans (in shares)     (87,055)      
Issuance of treasury stock under stock plans     $ 3      
Stock-based compensation, net of tax       10    
Net earnings (loss) attributable to Celanese Corporation $ 173       173  
Common stock dividends         (6)  
Other comprehensive income (loss), net of tax (54)         (55)
Balance as of the end of the period (in shares) at Jun. 30, 2025   109,501,876        
Balance as of the end of the period at Jun. 30, 2025 5,254 $ 0 $ (5,483) 419 11,221 (903)
Balance as of the end of the period (in shares) at Jun. 30, 2025     61,412,585      
Balance as of the beginning of the period, noncontrolling interest at Dec. 31, 2024 434          
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net earnings (loss) attributable to noncontrolling interests 7          
Other comprehensive income (loss), net of tax 1          
Distributions/dividends to noncontrolling interests (14)          
Balance as of the end of the period, noncontrolling interest at Jun. 30, 2025 428          
Balance as of the beginning of the period (in shares) at Mar. 31, 2025     61,499,640      
Balance as of the beginning of the period (in shares) at Mar. 31, 2025   109,403,403        
Balance as of the beginning of the period at Mar. 31, 2025   $ 0 $ (5,486) 413 11,027 (817)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock option exercises, shares   0        
Stock option exercises   $ 0        
Stock awards (in shares)   98,473        
Stock awards   $ 0        
Issuance of treasury stock under stock plans (in shares)     (87,055)      
Issuance of treasury stock under stock plans     $ 3      
Stock-based compensation, net of tax       6    
Net earnings (loss) attributable to Celanese Corporation 197       197  
Common stock dividends         (3)  
Other comprehensive income (loss), net of tax (85)         (86)
Balance as of the end of the period (in shares) at Jun. 30, 2025   109,501,876        
Balance as of the end of the period at Jun. 30, 2025 5,254 $ 0 $ (5,483) 419 11,221 (903)
Balance as of the end of the period (in shares) at Jun. 30, 2025     61,412,585      
Balance as of the beginning of the period, noncontrolling interest at Mar. 31, 2025 429          
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net earnings (loss) attributable to noncontrolling interests 3          
Other comprehensive income (loss), net of tax 1          
Distributions/dividends to noncontrolling interests (5)          
Balance as of the end of the period, noncontrolling interest at Jun. 30, 2025 428          
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Total equity 5,682          
Total equity 4,472         (776)
Balance as of the beginning of the period (in shares) at Dec. 31, 2025     61,348,064      
Balance as of the beginning of the period (in shares) at Dec. 31, 2025   109,570,157        
Balance as of the beginning of the period at Dec. 31, 2025 4,049 $ 0 $ (5,482) 431 9,876 (776)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock option exercises, shares   5,506        
Stock option exercises   $ 0        
Stock awards (in shares)   173,142        
Stock awards   $ 0        
Issuance of treasury stock under stock plans (in shares)     (60,765)      
Issuance of treasury stock under stock plans     $ 2      
Stock-based compensation, net of tax       19    
Net earnings (loss) attributable to Celanese Corporation 169       169  
Common stock dividends         (6)  
Other comprehensive income (loss), net of tax (62)         (66)
Balance as of the end of the period (in shares) at Jun. 30, 2026   109,748,805        
Balance as of the end of the period at Jun. 30, 2026 4,167 $ 0 $ (5,480) 450 10,039 (842)
Balance as of the end of the period (in shares) at Jun. 30, 2026     61,287,299      
Balance as of the beginning of the period, noncontrolling interest at Dec. 31, 2025 423          
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net earnings (loss) attributable to noncontrolling interests 8          
Other comprehensive income (loss), net of tax 4          
Distributions/dividends to noncontrolling interests (14)          
Balance as of the end of the period, noncontrolling interest at Jun. 30, 2026 421          
Balance as of the beginning of the period (in shares) at Mar. 31, 2026     61,348,064      
Balance as of the beginning of the period (in shares) at Mar. 31, 2026   109,661,338        
Balance as of the beginning of the period at Mar. 31, 2026   $ 0 $ (5,482) 439 9,917 (811)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock option exercises, shares   1,000        
Stock option exercises   $ 0        
Stock awards (in shares)   86,467        
Stock awards   $ 0        
Issuance of treasury stock under stock plans (in shares)     (60,765)      
Issuance of treasury stock under stock plans     $ 2      
Stock-based compensation, net of tax       11    
Net earnings (loss) attributable to Celanese Corporation 125       125  
Common stock dividends         (3)  
Other comprehensive income (loss), net of tax (29)         (31)
Balance as of the end of the period (in shares) at Jun. 30, 2026   109,748,805        
Balance as of the end of the period at Jun. 30, 2026 4,167 $ 0 $ (5,480) $ 450 $ 10,039 (842)
Balance as of the end of the period (in shares) at Jun. 30, 2026     61,287,299      
Balance as of the beginning of the period, noncontrolling interest at Mar. 31, 2026 422          
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net earnings (loss) attributable to noncontrolling interests 4          
Other comprehensive income (loss), net of tax 2          
Distributions/dividends to noncontrolling interests (7)          
Balance as of the end of the period, noncontrolling interest at Jun. 30, 2026 421          
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Total equity $ 4,588         $ (842)